Home
>
Resources
>
Statements

Statements

IFPMA and local pharmaceutical industry associations call on the African and global health communities to raise awareness about the dangers of substandard and falsified medical products

IFPMA and local pharmaceutical industry associations call on the African and global health communities to

10 June 2021

R&D bio-pharmaceutical groups warn about rise in COVID-19 falsified medical products in Africa and call governments to ratify the Medicrime Convention to crack down on illicit activities

R&D bio-pharmaceutical groups warn about rise in COVID-19 falsified medical products in Africa and call

10 June 2021

Global pharmaceutical industry response to G7 communiqués on antimicrobial resistance

Global pharmaceutical industry response to G7 communiqués on antimicrobial resistance

08 June 2021

WHA 74 - IFPMA-ICBA-GSCF Statement on agenda item 13.4 Global strategy and plan of action

25 May 2021

WHA 74 - IFPMA-ICBA-GSCF Statement on agenda item 17

24 May 2021

WHA 74 – IAPO-IAS-IDF-IEA-IHF-IFPMA-WFPHA-ISN-WONCA Statement on agenda item 13.1 Global action on patient safety

WHA 74 – IAPO-IAS-IDF-IEA-IHF-IFPMA-WFPHA-ISN-WONCA Statement on agenda item 13.1 Global action on patient safety

24 May 2021

COVID-19 vaccine makers invite G20 leaders to support the five steps to urgently advance COVID-19 vaccine equity

COVID-19 vaccine makers invite G20 leaders to support the five steps to urgently advance COVID-19

21 May 2021

COVID-19 Biopharmaceutical Industry – Regulatory Guiding Principles (May 2021)

COVID-19 Biopharmaceutical Industry – Regulatory Guiding Principles (May 2021)

11 May 2021

IFPMA Response on Joint Statement on transparency and data integrity by International Coalition of Medicines Regulatory Authorities (ICMRA) and the World Health Organization (WHO)

IFPMA Response on Joint Statement on transparency and data integrity by International Coalition of Medicines

07 May 2021

IFPMA Statement on WTO TRIPS Intellectual Property Waiver

IFPMA Statement on WTO TRIPS Intellectual Property Waiver

05 May 2021

IFPMA statement at the close of the 3rd Fair Pricing Forum 13 to 22 April 2021

IFPMA statement at the close of the 3rd Fair Pricing Forum 13 to 22 April

23 April 2021

IFPMA statement at WTO event “COVID-19 and Vaccine Equity: What can the WTO Contribute”

IFPMA statement at WTO event “COVID-19 and Vaccine Equity: What can the WTO Contribute”

15 April 2021

« Previous 1 … 3 4 5 6 7 … 20 Next »